Freeline
About:
Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.
Website: https://freeline.life
Twitter/X: FreelineLife
Top Investors: Innovate UK, Novo Holdings, Wellington Management, Acorn Bioventures, Eventide
Description:
Freeline is a clinical biotechnology company that develops transformative adeno-associated virus-vector-mediated systemic gene therapies. They use a designed AAV vector and capsid along with novel promoters and transgenes to deliver a functional copy of a therapeutic gene into human liver cells to express a functional level of the missing or dysfunctional protein into the patient’s bloodstream. Their development programs including clinical trials focus on developing products.
$302M
$50M to $100M
Stevenage, Herefordshire, United Kingdom
2015-01-01
contact(AT)freeline.life
Amit Nathwani, Markus Hörer
251-500
2022-03-10
Delisted
© 2025 bioDAO.ai